uk-dgm MCQ (SBA): Denosumab Discontinuation - Rebound Fracture Risk

Instant feedback + full explanation. One question, done properly.

HardFalls & Bone HealthDenosumab Discontinuation - Rebound Fracture Riskuk-dgm

A 74-year-old woman with osteoporosis has been on Denosumab 60 mg subcutaneously every 6 months for 3 years. She wants to stop the medication due to injection site reactions. What is the MOST important advice regarding Denosumab discontinuation?

Educational content. Not a substitute for clinical judgement or local policy.

uk-dgm MCQ: Denosumab Discontinuation - Rebound Fracture Risk — Answer